CES
CES (CESPLLSEC) is a homing peptide targeting Synaptosomal associated protein 25 (SNAP25) . CES specifically homes in intracranial U87MG and the WT-glioblastoma (GBM) model. CES can be used as a targeting peptide for drug delivery for cancers research[1].
Product Specifications
UNSPSC
12352209
Target
Others
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(N[C@@H](CSSC[C@@H](C(N)=O)NC1=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CO)C(N2[C@@H](CCC2)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@H]1CCC(O)=O)=O)=O)=O)=O)=O)=O)=O)C
Molecular Formula
C41H66N10O16S2
Molecular Weight
1019.15
References & Citations
[1]Arias AG, et al. A CYCLIC PEPTIDE TARGETS GLIOBLASTOMA BY BINDING TO ABERRANTLY EXPOSED SNAP25. bioRxiv [Preprint]. 2024 Sep 21:2024.09.18.613627.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
